To include your compound in the COVID-19 Resource Center, submit it here.

ALB-127158: Phase I data

A double-blind, placebo-controlled, U.K. Phase I trial showed that oral ALB-127158(a) was well tolerated and

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE